ストックスクリーナーアプリを入手
29.46
11.39%
3.04
前日終値:
$26.42
開ける：
$26.95
24時間の取引高:
1.14M
Relative Volume:
0.77
時価総額：
$915.42M
収益：
$117.67M
当期純損益:
$-1.88B
株価収益率:
-0.4866
EPS:
-60.5369
ネットキャッシュフロー:
$-621.36M
1週間 パフォーマンス:
+13.48%
1か月 パフォーマンス:
-2.84%
6か月 パフォーマンス:
+106.24%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$26.75
$29.79
1週間の範囲:
$25.12
$29.79
52週間の値動き範囲:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
GRAL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
29.44 | 915.42M | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
433.31 | 166.47B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
193.28 | 135.88B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
421.90 | 32.74B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.92 | 29.40B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.37 | 26.30B | 15.41B | 1.37B | 2.11B | 7.50 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-10-17 | 開始されました | Guggenheim | Neutral |
Grail Inc (GRAL) 最新ニュース
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga
Opinion | The FTC vs. the War on Cancer - WSJ
This Cancer Test Could Become Routine—and a Big Seller, Says Analyst - Barron's
Canaccord sets $32 target on GRAIL stock with buy rating By Investing.com - Investing.com Nigeria
Canaccord starts Grail with a Buy, sees ‘solid upside’ - TipRanks
Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target - marketscreener.com
Canaccord sets $32 target on GRAIL stock with buy rating - Investing.com Australia
GRAIL, Inc. (GRAL): A Bull Case Theory - Insider Monkey
Form DEF 14A GRAIL, Inc. For: May 29 - StreetInsider
GRAIL's Galleri Progresses While Back In Accumulation Levels - Seeking Alpha
AI-Powered Studio GRAiL Launched By Davide Bianca & Jeff Krelitz - Deadline
How Does GRAIL Benefit From The Proposed MCED Legislation? (NASDAQ:GRAL) - Seeking Alpha
Multi-Cancer Early Detection Market Critical Analysis with Expert Opinion| GRAIL, Natera, Elypta - openPR.com
Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet! - Yahoo Finance
Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion deal - MarketScreener
A Sydney company’s laser focus on energy’s holy grail - @AuManufacturing
Opinion | One ‘Monopoly’ That Could Save Your Life - The Wall Street Journal
Is GRAIL Stock About to Skyrocket? - timothysykes.com
GRAIL Careers, Perks + Culture - Built In
Debate Over Multi-Cancer Screening Tests Shifts Pending Grail Randomized Trial Results - GenomeWeb
FDA approval remains Holy Grail for Aussie biotechs - NT News
Biocurious: FDA approval remains the Holy Grail for ASX life science stocks - Stockhead
Grail price target raised to $20 from $16 at Morgan Stanley - TipRanks
Have Insiders Sold GRAIL Shares Recently? - Simply Wall St
Jim Cramer On Netflix, Inc. (NFLX) – Subscription Is the Holy Grail—Netflix Is Doing Very Well! - Insider Monkey
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Grail president Joshua Ofman sells $65,800 in common stock By Investing.com - Investing.com Australia
Grail CEO Robert Ragusa sells $237,976 in stock By Investing.com - Investing.com Canada
Grail CEO Robert Ragusa sells $237,976 in stock - Investing.com India
Grail president Joshua Ofman sells $65,800 in common stock - Investing.com
Oppenheimer & Co. Inc. Invests $190,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Rhumbline Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
New York State Common Retirement Fund Makes New $59,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail’s Stock Surge: An Eye on Future Moves - timothysykes.com
GRALGrail Inc Latest Stock News & Market Updates - StockTitan
Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025? - Yahoo Finance
Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey
Ieq Capital LLC Acquires Shares of 19,874 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (NASDAQ:GRAL) Trading 9.8% HigherWhat's Next? - MarketBeat
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail goes ‘Grey’s’: Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing - FiercePharma
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - Longview News-Journal
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN
GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey
Why Grail (GRAL) Is Falling Today - MSN
Van ECK Associates Corp Takes $475,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail initiated at equal weight by Morgan Stanley - MSN
Can GRAIL's Cancer Detection Technology Transform Healthcare? Key Presentation Coming March 4 - StockTitan
Putting early cancer detection to the test - Nature.com
GRAIL Q4 Loss Narrows, Revenue Up; Shares Rise After-Hours - MarketScreener
Grail Inc (GRAL) 財務データ
収益
当期純利益
現金流量
EPS
Grail Inc (GRAL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Ofman Joshua J. | President |
Mar 07 '25 |
Sale |
31.20 |
2,109 |
65,801 |
559,673 |
| Freidin Aaron | Chief Financial Officer |
Mar 07 '25 |
Sale |
31.20 |
1,816 |
56,659 |
335,170 |
4.80%
1.42%
大文字化:
|
ボリューム (24 時間):